Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Suh, Koung Jin | - |
dc.contributor.author | Cheong, June-Won | - |
dc.contributor.author | Kim, Inho | - |
dc.contributor.author | Kim, Hyeoung-Joon | - |
dc.contributor.author | Shin, Dong-Yeop | - |
dc.contributor.author | Koh, Youngil | - |
dc.contributor.author | Yoon, Sung -Soo | - |
dc.contributor.author | Min, Yoo Hong | - |
dc.contributor.author | Ahn, Jae-Sook | - |
dc.contributor.author | Kim, Yeo-Kyeoung | - |
dc.contributor.author | Lee, Yun-Gyoo | - |
dc.contributor.author | Lee, Jeong-Ok | - |
dc.contributor.author | Bang, Soo-Mee | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Seong, Chu-Myoung | - |
dc.contributor.author | Park, Yong | - |
dc.contributor.author | Kim, Byung-Soo | - |
dc.contributor.author | Hong, Junshik | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Kim, Sung -Yong | - |
dc.contributor.author | Lee, Hong Ghi | - |
dc.date.available | 2020-02-27T23:44:23Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-11-08 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7672 | - |
dc.description.abstract | Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to hypomethylating agents (HMA) is unknown. The prognostic impact of the revised International Prognostic Scoring System (IPSS-R) and for chromosomal translocations was assessed in 751 patients from the Korea MDS Registry. IPSS-R effectively discriminated patients according to leukaemia evolution risk and OS. We identified 40 patients (5.3%) carrying translocations, 30 (75%) of whom also fulfilled complex karyotype criteria. Translocation presence was associated with a shorter OS (median, 12.0 versus 79.7 months, P < 0.01). Multivariate analysis demonstrated that translocations (hazard ratio [HR] 1.64 [1.06-2.63]; P = 0.03) as well as age, sex, IPSS-R, and CK were independent predictors of OS. In the IPSS-R high and very high risk subgroup (n=260), translocations remained independently associated with OS (HR 1.68 [1.06-2.69], P = 0.03) whereas HMA treatment was not associated with improved survival (median OS, 20.9 versus 21.2 months, P = 0.43). However, translocation carriers exhibited enhanced survival following HMA treatment (median 2.1 versus 12.4 months, P = 0.03). Our data suggest that chromosomal translocation is an independent predictor of adverse outcome and has an additional prognostic value in discriminating patients with MDS having higher risk IPSS-R who could benefit from HMA treatment. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.subject | MONOSOMAL KARYOTYPE | - |
dc.subject | SCORING SYSTEM | - |
dc.subject | PHASE-III | - |
dc.subject | SURVIVAL | - |
dc.subject | MDS | - |
dc.subject | AZACITIDINE | - |
dc.subject | MUTATIONS | - |
dc.subject | STRATIFICATION | - |
dc.subject | OUTCOMES | - |
dc.title | Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000387615200076 | - |
dc.identifier.doi | 10.1371/journal.pone.0166245 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.11, no.11 | - |
dc.identifier.scopusid | 2-s2.0-84994410149 | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 11 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Hong, Junshik | - |
dc.contributor.affiliatedAuthor | Park, Jinny | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MONOSOMAL KARYOTYPE | - |
dc.subject.keywordPlus | SCORING SYSTEM | - |
dc.subject.keywordPlus | PHASE-III | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | MDS | - |
dc.subject.keywordPlus | AZACITIDINE | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | STRATIFICATION | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.